
Analysis finds mass‑production cost could be tiny compared with retail prices A recent cost analysis suggests that generic versions of the GLP‑1 medicines behind Wegovy and Ozempic could be manufactured for approximately $3 per person per month. The figure re…
A recent cost analysis suggests that generic versions of the GLP1 medicines behind Wegovy and Ozempic could be manufactured for approximately $3 per person per month. The figure refers to production … [+1476 chars]









